Clincosm LogoSign in Get a demo

rna virus infections

Showing 26 - 35 of 35
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Virus Diseases, RNA Virus Infections, Respiratory Tract Diseases Trial in Canada, United States (30 µg/strain of Quadrivalent

Completed
  • Virus Diseases
  • +3 more
  • 30 µg/strain of Quadrivalent VLP Vaccine
  • +3 more
  • Redding, California
  • +14 more
Oct 23, 2019

Hepatitis, Hepatitis C, Digestive System Diseases Trial (MK-3682B, Ribavirin)

Terminated
Has Results
  • Hepatitis
  • +7 more
  • (no location specified)
Jul 15, 2019

Influenza, Human, Orthomyxoviridae Infections, RNA Virus Infections Trial in Los Angeles (R/R - Autodialers, R/R - Texting, R/R

Completed
  • Influenza, Human
  • +7 more
  • R/R - Autodialers
  • +2 more
  • Los Angeles, California
    University of California, Los Angeles
Jun 4, 2019

Adverse Events Following Immunization With Butantan Trivalent

Completed
  • Influenza, Human
  • +6 more
  • Seasonal Influenza Vaccine
  • Sao Paulo, São Paulo, Brazil
  • +1 more
Jan 15, 2019

RNA Virus Infections, Flaviviridae Infections, Hepatitis C Trial in São Paulo (Vitamin D, Vitamin B 12)

Terminated
  • RNA Virus Infections
  • +3 more
  • Vitamin D
  • Vitamin B 12
  • São Paulo, Brazil
    Outpatient Clinic of Viral Hepatitis (NUPAIG)
Aug 23, 2016

HIV, AIDS, Lentivirus Infections Trial (Circumcision, Flexible sigmoidoscopy)

Completed
  • HIV Infections
  • +10 more
  • Circumcision
  • Flexible sigmoidoscopy
  • (no location specified)
Dec 10, 2015

Virus Diseases, RNA Virus Infections, Respiratory Tract Diseases Trial in Winnipeg (Low dose of H7 VLP vaccine + Alhydrogel, Med

Completed
  • Virus Diseases
  • +3 more
  • Low dose of H7 VLP vaccine + Alhydrogel
  • +4 more
  • Winnipeg, Manitoba, Canada
    Canadian Science Centre for Human and Animal Health
Sep 24, 2015

Influenza, Human, Orthomyxoviridae Infections, RNA Virus Infections Trial in Winnipeg (FVH1 - a DNA-based influenza vaccine)

Completed
  • Influenza, Human
  • +5 more
  • FVH1 - a DNA-based influenza vaccine
  • Winnipeg, Manitoba, Canada
    MS Building Health Sciences Centre
Apr 16, 2015

Virus Diseases, RNA Virus Infections, Respiratory Tract Diseases Trial in Toronto (20 micrograms dose H5 VLP, 30 micrograms dose

Completed
  • Virus Diseases
  • +3 more
  • 20 micrograms dose H5 VLP
  • +4 more
  • Toronto, Ontario, Canada
    Kendle Early Stage
Jul 30, 2012

Virus Diseases, RNA Virus Infections, Respiratory Tract Diseases Trial in Pierrefonds (H5 VLP pandemic influenza vaccine 5 µg,

Completed
  • Virus Diseases
  • +3 more
  • H5 VLP pandemic influenza vaccine 5 µg
  • +3 more
  • Pierrefonds, Quebec, Canada
    MUHC Vaccine Study Centre
Nov 2, 2010